Literature DB >> 30093565

A Novel Alternative Splicing Mechanism That Enhances Human 5-HT1A Receptor RNA Stability Is Altered in Major Depression.

Brice Le François1,2, Lei Zhang1, Gouri J Mahajan3, Craig A Stockmeier3, Eitan Friedman1, Paul R Albert4.   

Abstract

The serotonin-1A (5-HT1A) receptor is a key regulator of serotonergic activity and is implicated in mood and emotion. However, its post-transcriptional regulation has never been studied in humans. In the present study, we show that the "intronless" human 5-HT1A gene (HTR1A) is alternatively spliced in its 3'-UTR, yielding two novel splice variants. These variants lack a ∼1.6 kb intron, which contains an microRNA-135 (miR135) target site. Unlike the human HTR1A, the mouse HTR1A lacks the splice donor/accepter sites. Thus, in the mouse HTR1A, splicing was not detected. The two spliced mRNAs are extremely stable, are resistant to miR135-induced downregulation, and have greater translational output than the unspliced variant. Moreover, alternative HTR1A RNA splicing is oppositely regulated by the splice factors PTBP1 and nSR100, which inhibit or enhance its splicing, respectively. In postmortem human brain tissue from both sexes, HTR1A mRNA splicing was prevalent and region-specific. Unspliced HTR1A was expressed more strongly in the hippocampus and midbrain versus the prefrontal cortex (PFC), and correlated with reduced levels of nSR100. Importantly, HTR1A RNA splicing and nSR100 levels were reduced in the PFC of individuals with major depression compared with controls. Our unexpected findings uncover a novel mechanism to regulate HTR1A gene expression through alternative splicing of microRNA sites. Altered levels of splice factors could contribute to changes in regional and depression-related gene expression through alternative splicing.SIGNIFICANCE STATEMENT Alternative splicing, which is prevalent in brain tissue, increases gene diversity. The serotonin-1A receptor gene (HTR1A) is a regulator of serotonin, which is implicated in mood and emotion. Here we show that human HTR1A RNA is alternately spliced. Splicing removes a microRNA site to generate ultrastable RNA and increase HTR1A expression. This splicing varies in different brain regions and is reduced in major depression. We also identify specific splice factors for HTR1A RNA, showing they are also reduced in depression. Thus, we describe a novel mechanism to regulate gene expression through splicing. Altered levels of splice factors could contribute to depression by changing gene expression.
Copyright © 2018 the authors 0270-6474/18/388200-11$15.00/0.

Entities:  

Keywords:  5-HT1A receptor; RNA splice factors; RNA stability; alternative splicing; major depression; serotonin

Mesh:

Substances:

Year:  2018        PMID: 30093565      PMCID: PMC6596165          DOI: 10.1523/JNEUROSCI.0902-18.2018

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  49 in total

1.  The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing.

Authors:  Eugene V Makeyev; Jiangwen Zhang; Monica A Carrasco; Tom Maniatis
Journal:  Mol Cell       Date:  2007-08-03       Impact factor: 17.970

Review 2.  5-HT(1A) receptor function in major depressive disorder.

Authors:  Jonathan Savitz; Irwin Lucki; Wayne C Drevets
Journal:  Prog Neurobiol       Date:  2009-02-07       Impact factor: 11.685

Review 3.  Overview of microRNA biology.

Authors:  Ashley M Mohr; Justin L Mott
Journal:  Semin Liver Dis       Date:  2015-01-29       Impact factor: 6.115

Review 4.  Mechanisms and Regulation of Alternative Pre-mRNA Splicing.

Authors:  Yeon Lee; Donald C Rio
Journal:  Annu Rev Biochem       Date:  2015-03-12       Impact factor: 23.643

Review 5.  5-HT1A receptors, gene repression, and depression: guilt by association.

Authors:  Paul R Albert; Sylvie Lemonde
Journal:  Neuroscientist       Date:  2004-12       Impact factor: 7.519

6.  Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety.

Authors:  Jesse W Richardson-Jones; Caryne P Craige; Thanh H Nguyen; Hank F Kung; Alain M Gardier; Alex Dranovsky; Denis J David; Bruno P Guiard; Sheryl G Beck; René Hen; E David Leonardo
Journal:  J Neurosci       Date:  2011-04-20       Impact factor: 6.167

Review 7.  The serotonin 1A receptor gene confer susceptibility to mood disorders: results from an extended meta-analysis of patients with major depression and bipolar disorder.

Authors:  Taro Kishi; Reiji Yoshimura; Yasuhisa Fukuo; Tomo Okochi; Shinji Matsunaga; Wakako Umene-Nakano; Jun Nakamura; Alessandro Serretti; Christoph U Correll; John M Kane; Nakao Iwata
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-07-03       Impact factor: 5.270

8.  Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide.

Authors:  Sylvie Lemonde; Gustavo Turecki; David Bakish; Lisheng Du; Pavel D Hrdina; Christopher D Bown; Adolfo Sequeira; Neena Kushwaha; Stephen J Morris; Ajoy Basak; Xiao-Ming Ou; Paul R Albert
Journal:  J Neurosci       Date:  2003-09-24       Impact factor: 6.167

9.  Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia.

Authors:  Antonio L López-Figueroa; Camille S Norton; Manuel O López-Figueroa; Denise Armellini-Dodel; Sharon Burke; Huda Akil; Juan F López; Stanley J Watson
Journal:  Biol Psychiatry       Date:  2004-02-01       Impact factor: 13.382

Review 10.  Serotonin-prefrontal cortical circuitry in anxiety and depression phenotypes: pivotal role of pre- and post-synaptic 5-HT1A receptor expression.

Authors:  Paul R Albert; Faranak Vahid-Ansari; Christine Luckhart
Journal:  Front Behav Neurosci       Date:  2014-06-06       Impact factor: 3.558

View more
  6 in total

Review 1.  Genetic, epigenetic and posttranscriptional mechanisms for treatment of major depression: the 5-HT1A receptor gene as a paradigm

Authors:  Paul R. Albert; Brice Le François; Faranak Vahid-Ansari
Journal:  J Psychiatry Neurosci       Date:  2019-05-01       Impact factor: 6.186

2.  Key role of the 5-HT1A receptor addressing protein Yif1B in serotonin neurotransmission and SSRI treatment.

Authors:  Vincent Martin; Lionel Mathieu; Jorge Diaz; Haysam Salman; Jeanine Alterio; Caroline Chevarin; Laurence Lanfumey; Michel Hamon; Mark C Austin; Michèle Darmon; Craig A Stockmeier; Justine Masson
Journal:  J Psychiatry Neurosci       Date:  2020-09-01       Impact factor: 6.186

3.  Evolution Increases Primates Brain Complexity Extending RbFOX1 Splicing Activity to LSD1 Modulation.

Authors:  Chiara Forastieri; Maria Italia; Emanuela Toffolo; Elena Romito; Maria Paola Bonasoni; Valeria Ranzani; Beatrice Bodega; Francesco Rusconi; Elena Battaglioli
Journal:  J Neurosci       Date:  2022-03-29       Impact factor: 6.709

4.  CPEB3 regulates neuron-specific alternative splicing and involves neurogenesis gene expression.

Authors:  Wenrui Qu; Hongjuan Jin; Bing-Peng Chen; Jun Liu; Rui Li; Wenlai Guo; Heng Tian
Journal:  Aging (Albany NY)       Date:  2020-12-09       Impact factor: 5.682

5.  LSD1 is an environmental stress-sensitive negative modulator of the glutamatergic synapse.

Authors:  A Longaretti; C Forastieri; E Toffolo; L Caffino; A Locarno; I Misevičiūtė; E Marchesi; M Battistin; L Ponzoni; L Madaschi; C Cambria; M P Bonasoni; M Sala; D Perrone; F Fumagalli; S Bassani; F Antonucci; R Tonini; M Francolini; E Battaglioli; F Rusconi
Journal:  Neurobiol Stress       Date:  2020-11-27

6.  Co-Expression Network Modeling Identifies Specific Inflammation and Neurological Disease-Related Genes mRNA Modules in Mood Disorder.

Authors:  Chunxia Yang; Kun Zhang; Aixia Zhang; Ning Sun; Zhifen Liu; Kerang Zhang
Journal:  Front Genet       Date:  2022-03-21       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.